OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS (per bite)
A proprietary blend of malt, petrolatum and inulin
ACTIVE INGREDIENTS (per bite)
A proprietary blend of malt, petrolatum and inulin
INACTIVE INGREDIENTS
Wheat Flour, Chicken by-product meal, Glycerin, Natural Chicken Flavor, Gum Arabic, Salt, Caramel, Water, Sorbic Acid (a preservative), Methylparaben (a preservative), Propylparaben (a preservative), BHA (a preservative), Alpha-Tocopherol Acetate (a preservative)
CAUTIONS
Not suitable for kittens under 6 months of age.
If animal's condition worsens or does not improve, stop product administration and consult your veterinarian.
Federal law prohibits the off-label use of this product in ruminants.
Store in a cool, dry place away from direct sunlight.
Once opened use within one month.
For use in cats only.
Want to say goodbye to hairballs the easy way?
DIRECTIONS FOR USE
To prevent hairballs:
Kittens (over 6 months): 1 bite every second day
Adult Cats: 2 bites every second day
To remove hairballs:
Kittens (over 6 months): 3 bites per day for 4 days
Adult Cats: 6 bites per day for 4 days
Ensure fresh drinking water is always available for your pet.
WARNINGS
For animal use only.
Keep out of reach of children and other animals. In case of accidental overdose, contact a health care professional immediately.
Healthy Bites Hairball Remedy For Cats
Net Wt. 3oz (85g) e
| Class | Version | Type | Effective |
|---|---|---|---|
| BARLEY MALT Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20181113 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 28689-475-01 | Healthy Bites Hairball Remedy for Cats | 85 g in 1 POUCH | WAFER | 85 | 13 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Barley Malt Syrup | ACTIVE INGREDIENT | 22P8DKP670 | 13 | |
| Inulin | ACTIVE INGREDIENT | JOS53KRJ01 | 13 | |
| Petrolatum | ACTIVE INGREDIENT | 4T6H12BN9U | 13 | |
| Barley Malt | ACTIVE MOIETY | R3NBG8914U | 13 | |
| Inulin | ACTIVE MOIETY | JOS53KRJ01 | 13 | |
| Petrolatum | ACTIVE MOIETY | 4T6H12BN9U | 13 | |
| Acacia | INACTIVE INGREDIENT | 5C5403N26O | 13 | |
| Alpha-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 13 | |
| Butylated Hydroxyanisole | INACTIVE INGREDIENT | REK4960K2U | 13 | |
| Caramel | INACTIVE INGREDIENT | T9D99G2B1R | 13 | |
| Chicken | INACTIVE INGREDIENT | 0X8Q245Y7B | 13 | |
| Chicken Liver | INACTIVE INGREDIENT | 83GE7DVK04 | 13 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 13 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 13 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 13 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 13 | |
| Sorbic Acid | INACTIVE INGREDIENT | X045WJ989B | 13 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 13 | |
| Wheat | INACTIVE INGREDIENT | 4J2I0SN84Y | 13 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 28689-475 | 28689-475-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Barley Malt Syrup | 22P8DKP670 | ACTIB |
| Petrolatum | 4T6H12BN9U | ACTIB |
| Inulin | JOS53KRJ01 | ACTIB |
| Wheat | 4J2I0SN84Y | IACT |
| Chicken | 0X8Q245Y7B | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Chicken Liver | 83GE7DVK04 | IACT |
| Acacia | 5C5403N26O | IACT |
| Sodium Chloride | 451W47IQ8X | IACT |
| Caramel | T9D99G2B1R | IACT |
| Water | 059QF0KO0R | IACT |
| Sorbic Acid | X045WJ989B | IACT |
| Methylparaben | A2I8C7HI9T | IACT |
| Propylparaben | Z8IX2SC1OH | IACT |
| Butylated Hydroxyanisole | REK4960K2U | IACT |
| Alpha-Tocopherol Acetate | 9E8X80D2L0 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET / SUBLINGUAL | 0.16 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SYRUP / ORAL | 81 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | LIQUID / ORAL | 162 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SUBCUTANEOUS | 2 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, CHEWABLE / ORAL | 20 mg | ||
| Butylated Hydroxyanisole | BUTYLATED HYDROXYANISOLE | REK4960K2U | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / SUBCUTANEOUS | 0.02 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / INTRATYMPANIC | 2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SHAMPOO / TOPICAL | 0.03 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERIDURAL | 8.07 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBARACHNOID | 0.9 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / INFILTRATION | 80 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.68 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE, EXTENDED RELEASE / ORAL | 41 mg | ||
| Butylated Hydroxyanisole | BUTYLATED HYDROXYANISOLE | REK4960K2U | TABLET / SUBLINGUAL | 2 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | DROPS / AURICULAR (OTIC) | NA | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SUSPENSION / INTRAMUSCULAR | 0.02 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, DENTIFRICE / DENTAL | 0.03 mg/mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SYSTEM / IONTOPHORESIS | 3.1 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INTRATHECAL | 131 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / NASAL | 140 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRALESIONAL | 0.15 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / EPIDURAL | 0.9 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / OPHTHALMIC | 0.01 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SOFT TISSUE | 26 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | 45 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION/ DROPS / OPHTHALMIC | 0.01 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAMUSCULAR | 90 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | TABLET, COATED / ORAL | 54.7 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / OPHTHALMIC | 0.02 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / AURICULAR (OTIC) | 18 mg | ||
| Butylated Hydroxyanisole | BUTYLATED HYDROXYANISOLE | REK4960K2U | SUPPOSITORY / VAGINAL | 1 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.86 %w/v | ||
| Butylated Hydroxyanisole | BUTYLATED HYDROXYANISOLE | REK4960K2U | SUSPENSION / ORAL | 2.5 mg/5ml | ||
| Butylated Hydroxyanisole | BUTYLATED HYDROXYANISOLE | REK4960K2U | GRANULE, FOR SUSPENSION / ORAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 15 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAMUSCULAR | 6 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | 420 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA |
Adverse event summaries are temporarily unavailable. Other product information remains available.